Retinoblastoma

+ -Text Size

Other Resources and References TOPICS

References: Retinoblastoma detailed guide

Dimaras H, Kimani K, Dimba EA. Retinoblastoma. Lancet. 2012;379:1436–1446.

Dome JS, Rodriguez-Galindo C, Spunt SL, Santana VM. Chapter 95: Pediatric solid tumors. In: Niederhuber JE, Armitage JO, Dorshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 5th ed. Philadelphia, Pa. Elsevier: 2014.

Dunkel IJ, Jubran RF, Gururangan S, et al. Trilateral retinoblastoma: Potentially curable with intensive chemotherapy. Pediatr Blood Cancer. 2010:54:384–387.

Gobin YP, Dunkel IJ, Marr BP, Brodie SE, Abramson DH. Intra-arterial chemotherapy for the management of retinoblastoma: Four-year experience. Arch Ophthalmol. 2011;129:732–737.

Howlader N, Noone AM, Krapcho M, et al (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.

Hurwitz RL, Shields CL, Shields JA, et al. Retinoblastoma. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 6th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2011: 809–837.

Lin P, O’Brien JM. Frontiers in the management of retinoblastoma. Am J Ophthalmol. 2009;148:192–198.

Marees T, Moll AC, Imhof SM, et al. Risk of second malignancies in survivors of retinoblastoma: More than 40 years of follow-up. J Natl Cancer Inst. 2008;100:1771–1779.

National Cancer Institute. Physician Data Query (PDQ). Retinoblastoma Treatment. 2015. Accessed at www.cancer.gov/cancertopics/pdq/treatment/retinoblastoma/healthprofessional on February 12, 2015.

Pappo AS, Navid F, Brennan RC, et al. Chapter 99: Solid tumors of childhood. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2015.

Rodriguez-Galindo C, Orbach DB, VanderVeen D. Retinoblastoma. Pediatr Clin North Am. 2015;62:201–223.

Rushlow DE, Mol BM, Kennett JY, et al. Characterisation of retinoblastomas without RB1 mutations: Genomic, gene expression, and clinical studies. Lancet Oncol. 2013;14:327–334.

Saunders T, Margo CE. Intraocular medulloepithelioma. Arch Pathol Lab Med. 2012;136:212–216.

Shields CL, Manjandavida FP, Arepalli S, et al. Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: Preliminary results. JAMA Ophthalmol. 2014;132:319–325.

Wilson MW, Haik BG, Liu T, et al. Effect on ocular survival of adding early intensive focal treatments to a two-drug chemotherapy regimen in patients with retinoblastoma. Am J Ophthalmol. 2005;140:397–406.

Zhang J, Benavente CA, McEvoy J, et al. A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature. 2012;481:329–334.


Last Medical Review: 03/12/2015
Last Revised: 03/12/2015